Dianthus Therapeutics (DNTH) Receivables - Other (2018 - 2024)
Historic Receivables - Other for Dianthus Therapeutics (DNTH) over the last 5 years, with Q4 2024 value amounting to $807000.0.
- Dianthus Therapeutics' Receivables - Other rose 30350.0% to $807000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $807000.0, marking a year-over-year increase of 30350.0%. This contributed to the annual value of $200000.0 for FY2024, which is 0.0% changed from last year.
- Dianthus Therapeutics' Receivables - Other amounted to $807000.0 in Q4 2024, which was up 30350.0% from $1.3 million recorded in Q3 2024.
- Over the past 5 years, Dianthus Therapeutics' Receivables - Other peaked at $1.3 million during Q3 2024, and registered a low of $200000.0 during Q4 2023.
- Over the past 3 years, Dianthus Therapeutics' median Receivables - Other value was $800000.0 (recorded in 2024), while the average stood at $703714.3.
- In the last 5 years, Dianthus Therapeutics' Receivables - Other plummeted by 7777.78% in 2023 and then soared by 30350.0% in 2024.
- Quarter analysis of 3 years shows Dianthus Therapeutics' Receivables - Other stood at $900000.0 in 2022, then tumbled by 77.78% to $200000.0 in 2023, then surged by 303.5% to $807000.0 in 2024.
- Its last three reported values are $807000.0 in Q4 2024, $1.3 million for Q3 2024, and $800000.0 during Q2 2024.